from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1445c/devB

LFCtreatmentdescriptionclass of inhibitor

-0.596

Amikacinug/mL Amikacintranslation

-2.764

Cap5-10ug/mL Capreomycintranslation

-2.289

Rox10-50 ug/mL Roxithromycintranslation

-0.170

SM2-5 ug/mL Streptomycintranslation

-1.169

Tet5-10 ug/mL Tetracyclinetranslation

0.272

Rif0.2-5ug/mL Rifampicintranscription

0.176

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.337

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.455

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.599

CPZ10-50 ug/mL Chlorpromazinerespiration

1.730

Clofazimine10-13 ug/mL Clofaziminerespiration

0.591

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.896

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.360

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.220

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.298

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.764

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.719

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.448

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.157

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.133

Nigericin50 uM Nigericinrespiration

0.446

TRC10-150 ug/mL Triclosanrespiration

0.987

TRZ10-25 ug/mL Thioridazinerespiration

-0.734

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.491

menadione6-10 ug/mL Menadionerespiration

0.423

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.303

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.380

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.170

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.904

NRP_1Non-replicating persistence stage 1dosRassociated

-0.004

Amp0.2mg/mL AmpicillincellWall

0.419

Cephalexin20-100 ug/mL CephalexincellWall

0.146

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.430

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.288

EMB10-20 ug/mL EthambutolcellWall

-0.065

Eta12-40 ug/mL EthionamidecellWall

0.026

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.026

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.683

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.410

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.164

BZA0.12 mg/mL BenzamidearomaticAmides

0.215

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.247

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.830

H2O24 mM hydrogen peroxideDNAdamaging

-0.020

Levo10 ug/mL LevofloxacinDNAdamaging

0.208

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.503

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.191

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.116

UVUV-irradiationDNAdamaging

0.019

ARP41-4 ug/mL Antitubercular compound ARP4?

0.420

Antimycin12.5-50 ug/mL Antimycin A?

-1.006

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.309

PA_110-50 ug/mL Antitubercular compound PA-1?

0.420

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.910

PA8240.2-2 ug/mL PA-824?

0.290

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.847

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.083

Verapamil50 uM Verapamil?

-0.816

mercaptoethanol2 mM 2-Mercaptoethanol?

0.555

methoxatin10-20 ug/mL Methoxatin?